7Chi Zhisheng，Diabetes in Epidemiological Perspective，1983年，78页
82，Martin P. Tuberculosis at the end of the century. Med Dig,1996,4(1):10.
93，Frasca D,Adorini L,Doria G. Enhanced frequency of mitogenresponsive T-cell precursorsin old mice. Eur J Immunol,1987,17(10):727～730.
104，Frasca D,Adorini L,Doria G. Enhancement of helper and suppressor T-cell activites bythymosin α1 injection in old mice. Immunophar,1985,10(1):41～49.
4Raviglione MC, Smith IM. XDR tuberculosis-implications for global public health[J]. N Engl J Med,2007,356(7) :656 - 659.
5Dye C, Scheele S, Bolin P, et al. Consensus statement . Global burden of tuberculosis: estimated incidence, prevalance, and mortality by country. WHO global surveillance.and monitoring project [J]. JAMA, 1999,282 : 677 - 686.
6Johnson R, Warren R, Strauss OJ, et al. An outbreak of drug-resistant tuberculosis caused by a Beijing strain in the western Cape,South Atrica[ J ]. Int J Tuberc Lung Dis, 2006, 10 (12):1412 - 1414.
7Narayan KM, Gregg EW, Fagot CA, et al. Diabetes - a common. growing, serious, costly, and potentially preventable public health problem [ J ]. Diabetes Res Clin Pract, 2000,50 (12) : 77 - 84.
8Feleke Y, Abdulkadir J, Ademye G. Prevalence and clinical features of tuberculosis in Ethiopian diabetic patients[J]. East At, Med J, 1999,76 : 361 - 364.
9Bashar M, Alcabes P, Rom WN, et al. Increase incidence of multidrug resistant tuberculosis in diabetic patients on the Bellevue chest service, 1987 to 1997 [J]. Chest, 2001,120(5) : 1514 - 1519.
10Perez A, Brown HS, Restrepo B. Association between tuberculosis and diabetes in the Mexican border and non-border regions of Texas [J]. Am J Trop Med Hyg, 2006,74(4) :604 - 611.
